Navana Pharmaceuticals PLC reported earnings results for the second quarter and six months ended December 31, 2023. For the second quarter, the company reported sales was BDT 1,652.12 million compared to BDT 1,395.86 million a year ago. Net income was BDT 104.77 million compared to BDT 70.93 million a year ago. Basic earnings per share from continuing operations was BDT 0.98 compared to BDT 0.77 a year ago.
For the six months, sales was BDT 3,283.64 million compared to BDT 2,731.99 million a year ago. Net income was BDT 224.32 million compared to BDT 143.56 million a year ago. Basic earnings per share from continuing operations was BDT 2.09 compared to BDT 1.57 a year ago.